MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION

MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION

Show other versions (1)

<p>Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation.</p>

Bibliographic Details
Main Authors:	Frans Van de Werf, Jeroen Bax, Amadeo Betriu, Carina Blomstrom-Lundqvist, Filippo Crea, Volkmar Falk, Gerasimos Filippatos, Keith Fox, Kurt Huber, Adnan Kastrati, Annika Rosengren, P. Gabriel Steg, Marco Tubaro, Freek Verheugt, Franz Weidinger, Michael Weis, M. O. Evseev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	инфаркт миокарда подъем сегмента ST ишемическая болезнь сердца реперфузионная терапия вторичная профилактика
Online Access:	http://www.rpcardio.ru/jour/article/view/722

Similar Items

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

ELECTROCARDIOGRAM ST SEGMENT DEPRESSION AND ELEVATION IN STRESS-TESTING
by: D. A. Kuzhel, et al.
Published: (2015-09-01)

Comparison of medicamental secondary prevention of cardiovascular disease in ambulatory patients with myocardial infarction over a period of 2001-2006 (pharmacoepidemiological study)
by: S B Fitilev, et al.
Published: (2009-03-01)

PARTICULARITĂȚI CLINICE ȘI DE MANAGEMENT ALE PACIENȚILOR CU INFARCT MIOCARDIC FĂRĂ SUPRADENIVELAREA SEGMENTULUI ST CU ARTERE CORONARE NON-OBSTRUCTIVE
by: Olga DICUSAR, et al.
Published: (2024-08-01)

RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL
by: J. L. Mega, et al.
Published: (2015-09-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

RELEVANCE AND ROLE OF RISK FACTORS IN THE DEVELOPMENT OF MYOCARDIAL INFARCTION
by: Андрей Георгиевич Петров, et al.
Published: (2021-06-01)

Primenenie Trimetazidina? pri ishemicheskoy bolezni serdtsa v sochetanii s sakharnym diabetom
by: Yu A Fedotkina, et al.
Published: (2002-06-01)

Primenenie Sibutramina (meridia) v terapii bol'nykh sakharnym diabetom tipa 2
by: S A Butrova
Published: (2002-06-01)

IMPORTANCE OF SCREENING FOR PHARMACEUTICAL AND MEDICAL PREVENTION OF CARDIOVASCULAR DISEASES
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

Multi-center randomized trial on the impact of “CONFIDENCE” communication program aimed at evaluating therapy adherence of patients with registered myocardial infarction who underwent successful revascularization by stenting or thrombolysis after discharg
by: А. Р. Таркова, et al.
Published: (2017-04-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I)
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

ГИПОАГРЕГАЦИОННЫЙ ЭФФЕКТ У БОЛЬНЫХ ИНФАРКТОМ МИОКАРДА С ПОДЪЕМОМ СЕГМЕНТА ST ПРИ ЗАМЕНЕ КЛОПИДОГРЕЛА НА ТИКАГРЕЛОР
Published: (2016-12-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

PROBLEMS OF RATIONAL CHOICE OF MEDICINAL PREPARATIONS IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Николай Владимирович Абрамов, et al.
Published: (2024-02-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION)
by: V. A. Sulimov
Published: (2015-09-01)

The effect of depressive disorder on the clinical presentation of coronary artery disease and five-year survival of patients after myocardial infarction
by: T. G. Nonka, et al.
Published: (2022-10-01)

Factors associated with right ventricular dilatation in coronary artery disease patients with prior Q-wave myocardial infarction
by: В. А. Кузнецов, et al.
Published: (2015-10-01)

Феномен коронарной микрососудистой обструкции (no-reflow) при проведении чрескожных коронарных вмешательств у пациентов с инфарктом миокарда
by: А. Фролов, et al.
Published: (2020-04-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

Результаты коронарного шунтирования у пациентов с острым коронарным синдромом без подъема сегмента ST высокого риска, выполненного в первые 24 часа
by: А. Нишонов, et al.
Published: (2020-07-01)

Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

ИМПЛАНТАЦИЯ АУТОЛОГИЧНЫХ МОНОНУКЛЕАРОВ КОСТНОГО МОЗГА КАК ПЕРВЫЙ ЭТАП КОМПЛЕКСНОГО ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА В СОЧЕТАНИИ С АОРТОКОРОНАРНЫМ ШУНТИРОВАНИЕМ
Published: (2015-12-01)

Possibilities of detecting and correcting decreased heart rate variability in patients with coronary artery disease in combination with depressive disorders in a cardiology department
by: T. G. Nonka, et al.
Published: (2021-07-01)

TYPE 2 MYOCARDIAL INFARCTION: CLINICAL AND DEMOGRAPHIC FEATURES, LABORATORY AND INSTRUMENTAL ASSOCIATIONS
by: H T Hoang, et al.
Published: (2018-12-01)

Problemy ostrogo infarkta miokarda u bol'nykh sakharnym diabetom: ekho Myunkhena
by: Ivan Ivanovich Dedov, et al.
Published: (2008-03-01)

ИНФАРКТ МИОКАРДА ВТОРОГО ТИПА ПРИ ВЫРАЖЕННОМ АОРТАЛЬНОМ СТЕНОЗЕ
by: Алексей Викторович Сизов, et al.
Published: (2022-04-01)

EFFECT OF LONG-TERM EXPOSURE TO LOWER LOW-DENSILIPOPROTEIN CHOLESTEROL BEGINNING EARLY IN LIFE ON THE RISK OF CORONARY HEART DISEASE. A MENDELIAN RANDOMIZATION ANALYSIS
by: B. A. Ference, et al.
Published: (2015-09-01)

Аспирационная тромбэктомия при остром инфаркте миокарда через призму критического анализа современных исследований
by: Е.С. Гергерт, et al.
Published: (2024-12-01)

GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES
by: P. A. Shesternya, et al.
Published: (2012-02-01)

Кардиопротекторные свойства хлорида лития на модели инфаркта миокарда у крыс
by: О. Гребенчиков, et al.
Published: (2019-10-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP)
by: V. A. Shulman, et al.
Published: (2015-12-01)

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2009-03-01)

Not indenturing ami on clinic was course intraoperative left ventricular rupture
by: Y V Tarichko, et al.
Published: (2009-03-01)

CONCEPT OF MEDICAL AND PHARMACEUTICAL CARE FOR MYOCARDIAL INFARCTION AS A PROSPECTIVE FORM OF SERVICE TO THE POPULATION
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015-11-01)